What is NDC 70069-747?

70069-747 is the product NDC for Potassium Phosphate, Monobasic potassium phosphate 224 mg/mL; Dibasic potassium phosphate 236 mg/mL injection, solution, listed with the FDA by Somerset Therapeutics, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.

What is the active ingredient?

Monobasic potassium phosphate, Dibasic potassium phosphate.

Somerset Therapeutics, LLC, NDC labeler code 70069. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Potassium Phosphate?

1 other product NDC are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Potassium Phosphate NDC 70069-747 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)70069-747Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70069-0747Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70069-747-25	7006907472570069074725	25 BOTTLE in 1 CARTON (70069-747-25) / 15 mL in 1 BOTTLEMarketed from Jul 11, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Potassium Phosphate
Generic name (nonproprietary): potassium phosphate
Active ingredients: Monobasic potassium phosphate — 224 mg/mLDibasic potassium phosphate — 236 mg/mL
Dosage form: Injection, Solution
Route: Intravenous
Labeler: Somerset Therapeutics, LLCNDC labeler code 70069
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 217726
Marketing start: Jul 11, 2024
Listing expires: Dec 31, 2026
Other FDA classes: Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Potassium Compounds (Chemical structure)Potassium Compounds (Chemical structure)
Identifiers: Product ID 70069-747_d9961ad1-b332-4cfa-8072-6263917b9788SPL ID d9961ad1-b332-4cfa-8072-6263917b9788SPL set ID 52f07402-1869-4a97-9c92-9729dc611f85RxCUI 1928567, 1928569UNII CI71S98N1Z, 4J9FJ0HL51UPC 0370069747254, 0370069746257, 0370069747018, 0370069746011
Pharmacologic class: Osmotic Laxative; Potassium Salt

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N470069074725 followed by a unit qualifier and the quantity

Package 70069-0747-25. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 11, 2024.

Indications (excerpt from the label)

Potassium phosphates injection is indicated as a source of phosphorus: in intravenous fluids to correct hypophosphatemia in adults and pediatric patients when oral or enteral replacement is not possible, insufficient or contraindicated. for parenteral nutrition in adults and pediatric patients when oral or enteral nutrition is not possible, insufficient or contraindicated. Potassium Phosphates Injection is a phosphorus replacement product indicated as a source of phosphorus: in intravenous fluids to correct hypophosphatemia in adults and pediatric patients when oral or enteral replacement is not possible, insufficient or contraindicated. (1) for parenteral nutrition in adults and pediatric p…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 70069-747

What is NDC 70069-747?: 70069-747 is the product NDC for Potassium Phosphate, Monobasic potassium phosphate 224 mg/mL; Dibasic potassium phosphate 236 mg/mL injection, solution, listed with the FDA by Somerset Therapeutics, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Potassium Phosphate.
What is the active ingredient?: Monobasic potassium phosphate, Dibasic potassium phosphate.
Who is the labeler?: Somerset Therapeutics, LLC, NDC labeler code 70069. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Potassium Phosphate?: 1 other product NDC are listed under this name. See all Potassium Phosphate NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Potassium Phosphate NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Potassium Phosphate	Monobasic potassium phosphate 224 mg/mL; Dibasic potassium phosphate 236 mg/mL	Injection, SolutionIntravenous	Somerset Therapeutics, LLC	70069-746	70069-0746-25

Other NDCs under ANDA 217726

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 217726
Product	Strength	Form · route	Labeler	Product NDC
Potassium Phosphate	Monobasic potassium phosphate 224 mg/mL; Dibasic potassium phosphate 236 mg/mL	Injection, SolutionIntravenous	Somerset Therapeutics, LLC	70069-746